麻省理工学院科赫综合癌症研究所结合麻省理工学院丰富的跨学科探究和技术创新传统以及对癌症基础生物学的最先进研究，加速发现和应用检测、监测、治疗和预防疾病的新方法。在科赫研究所，充满活力的生命科学家和工程师社区将麻省理工学院的精华带入癌症研究，通过跨学科工作提出问题并大胆创意。研究模型建立生命科学与工程和物理科学的结合协作基础上。
研究所提供可以广泛应用于一系列癌症的知识和工具，对患者的生活质量和生存产生重大影响。作为国家癌症研究所指定的基础癌症研究中心，研究重点是发现科学和开发新技术，进而提高患者生存率和生活质量。通过与学术、临床和行业合作伙伴以及教师创立的初创公司的广泛合作，研究所的发现和创新可以尽快转化为癌症的工具和治疗方法。
科赫研究所交叉结合生物学、化学、机械和材料科学、计算机科学等抗击癌症，专注于五个战略领域：基于纳米技术的药物、检测和监测，癌细胞转移，精准医学以及免疫学和免疫疗法。通过在这些工作取得变革性的进步，以发现并构建能够对患者生存产生最大影响并改善其生活质量的工具。
MIT's Koch Institute for Comprehensive Cancer Research combines MIT's rich tradition of interdisciplinary inquiry and technological innovation with state-of-the-art research in the underlying biology of cancer to accelerate the discovery and application of new methods of detecting, monitoring, treating, and preventing disease. At the Koch Institute, a vibrant community of life scientists and engineers brings the best of MIT into cancer research, asking questions and bold ideas through interdisciplinary work. Research models build on the combined collaboration between life sciences and engineering and physical sciences.
The Institute provides knowledge and tools that can be widely used across a range of cancers, with a significant impact on the quality of life and survival of patients. As a designated basic cancer research center by the National Cancer Institute, the research focus is on discovering science and developing new technologies to improve patient survival and quality of life. Through extensive collaboration with academic, clinical, and industry partners, as well as faculty-founded startups, the Institute's discoveries and innovations can be translated into tools and treatments for cancer as quickly as possible.
The Koch Institute cross-integrates biology, chemistry, mechanical and materials science, computer science, and more to fight cancer, focusing on five strategic areas: nanotechnology-based drugs, detection and surveillance, cancer cell metastasis, precision medicine, and immunology and immunotherapy. Transformative advances in these efforts to identify and build tools that have the greatest impact on patient survival and improve their quality of life.